Centre de Recherche en Reproduction et Fertilité, Université de Montréal, St-Hyacinthe, Qc, J2S 2M2, Canada.
Centre de Recherche en Reproduction et Fertilité, Université de Montréal, St-Hyacinthe, Qc, J2S 2M2, Canada.
Mol Aspects Med. 2021 Apr;78:100937. doi: 10.1016/j.mam.2020.100937. Epub 2020 Dec 4.
The development of the ovarian follicle to its culmination by ovulation is an essential element of fertility. The final stages of ovarian follicular growth are characterized by granulosa cell proliferation and differentiation, and steroid synthesis under the influence of follicle-stimulating hormone (FSH). The result is a population of granulosa cells poised to respond to the ovulatory surge of luteinizing hormone (LH). Members of the nuclear receptor superfamily of transcription factors play indispensable roles in the regulation of these events. The key regulators of the final stages of follicular growth that precede ovulation from this family include the estrogen receptor beta (ESR2) and the androgen receptor (AR), with additional roles for others, including steroidogenic factor-1 (SF-1) and liver receptor homolog-1 (LRH-1). Following the LH surge, the mural and cumulus granulosa cells undergo rapid changes that result in expansion of the cumulus layer, and a shift in ovarian steroid hormone biosynthesis from estradiol to progesterone production. The nuclear receptor best associated with these events is LRH-1. Inadequate cumulus expansion is also observed in the absence of AR and ESR2, but not the progesterone receptor (PGR). The terminal stages of ovulation are regulated by PGR, which increases the abundance of the proteases that are directly responsible for rupture. It further regulates the prostaglandins and cytokines associated with the inflammatory-like characteristics of ovulation. LRH-1 regulates PGR, and is also a key regulator of steroidogenesis, cellular proliferation, and cellular migration, and cytoskeletal remodeling. In summary, nuclear receptors are among the panoply of transcriptional regulators with roles in ovulation, and several are necessary for normal ovarian function.
卵巢卵泡的发育直至排卵是生育能力的重要组成部分。卵泡生长的最后阶段的特征是颗粒细胞的增殖和分化,以及在卵泡刺激素(FSH)的影响下合成甾体。其结果是一群颗粒细胞准备对黄体生成素(LH)的排卵激增做出反应。核受体超家族转录因子成员在这些事件的调节中起着不可或缺的作用。该家族中,在排卵前卵泡生长的最后阶段的关键调节剂包括雌激素受体β(ESR2)和雄激素受体(AR),其他调节剂还包括类固醇生成因子-1(SF-1)和肝受体同系物-1(LRH-1)。在 LH 激增之后,壁层和卵丘颗粒细胞发生迅速变化,导致卵丘层扩张,以及卵巢甾体激素生物合成从雌二醇向孕激素生产的转变。与这些事件最相关的核受体是 LRH-1。在缺乏 AR 和 ESR2 的情况下,也观察到卵丘扩张不足,但孕激素受体(PGR)没有。排卵的终末阶段由 PGR 调节,PGR 增加了直接负责破裂的蛋白酶的丰度。它进一步调节与排卵的炎症样特征相关的前列腺素和细胞因子。LRH-1 调节 PGR,也是甾体生成、细胞增殖和细胞迁移以及细胞骨架重塑的关键调节剂。总之,核受体是参与排卵的转录调节剂的总称,其中几个对于正常卵巢功能是必需的。